Jennerex Biotherapeutics' Grant

Jennerex Biotherapeutics raised a round of funding on June 23, 2009. Investors include Ontario Institute for Cancer Research.

Jennerex is a clinical-stage biopharmaceutical company focused on the development and commercialization of first-in-class, breakthrough targeted oncolytic products for cancer. The company's lead produ…

Articles about Jennerex Biotherapeutics' Grant: